Search Tag: Cynosure

IMAGING Management

Hologic Receives CE Mark to Market SculpSure® for Non-Invasive Body Contouring of the Submental Area

2017 19 Oct

Patients in Clinical Studies Report 100% Satisfaction Hologic, Inc. (Nasdaq: HOLX) has announced that it has received an additional European Medical Device Directive (MDD) certification for SculpSure®, a state-of-the-art body contouring laser treatment. The device is now certified to treat a double chin (also known as the submental area),... Read more

IMAGING Management

Hologic receives FDA 510(k) clearance to market SculpSure® for non-invasive body contouring

2017 30 Sep

Patients in Clinical Studies Report 100% Satisfaction Rate   Hologic, Inc. (Nasdaq: HOLX) has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded FDA 510(k) clearance for Cynosure's non-invasive body contouring product,  SculpSure ®. The state-of-the-art body contouring laser treatment is now cleared to treat... Read more

IMAGING Management

Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure®

2017 16 Jun

SculpSure Now Cleared to Treat Five Areas of the Body Hologic, Inc. (Nasdaq: HOLX) has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for Cynosure's non-invasive body contouring product,  SculpSure , to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for... Read more

IMAGING Management

Hologic to Acquire Cynosure,in All-Cash Tender Offer that Combines Two Complementary Businesses

2017 14 Feb

-Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate  -Accelerates Hologic's Top- and Bottom-Line Growth Rates and is Immediately Accretive to Non-GAAP Earnings per Share  \ Hologic, Inc. (Nasdaq: HOLX), a leader in women's health, and Cynosure, Inc. (Nasdaq: CYNO), a leader... Read more